Sector expertise
We specialize in four sectors that are poised for robust and sustainable growth – Health & Wellness, the Food Value Chain, Technology, and Business Services – where our private equity expertise gives us a valuable competitive advantage. Ardian provides our portfolio companies with a strategic partner that offers in-depth market experience and an extensive network within the sector.
-
120+
investments since 1998
-
BuyoutUnither
France
IndustrialsExited
IndustrialsFounded in 1993 from the takeover of a Sanofi facility in Amiens, Unither Pharmaceuticals is a Contract Development and Manufacturing Organization (CDMO). With annual revenues of +250 M€ and a team of more than 1,200 professionals, Unither Pharmaceuticals operates 6 manufacturing sites and 1 R&D center in France, USA and Brazil.
Deal team
Press releases
-
BuyoutSLV
Germany
Consumer goods and servicesConsumer goods and servicesFounded more than 35 years ago and headquartered in Übach-Palenberg, Germany, SLV has experienced significant growth over the past decades and became a leading provider of lighting fixtures in its core markets. With its assets-light business model, SLV offers its customers a diversified and innovation driven product offering from functional towards decorative lighting fixtures for indoor and outdoor use with immediate availability of its products.
Deal team
Press releases
-
BuyoutWeber Automotive
Germany
IndustrialsExited
IndustrialsWeber Automotive, founded by Albert Weber in 1969, today is a technological leader of the global vehicle supply industry. The Company is managed by Daniel Weber (CEO) and Christian Weber (COO), the two sons of Albert Weber, as well as Sven Hattwig (CFO). Weber produces drive components for passenger cars, heavy trucks and powersport vehicles. The focus lies on the processing of complex engine and transmission components as well as the assembly of complete systems. Weber currently employs over 1,300 highly qualified and motivated employees in six production sites across Germany, Hungary and the USA.
Deal team
-
BuyoutKersia
France
Healthcare & life scienceExited
Healthcare & life scienceHeadquartered in Dinard (France, Brittany), Kersia (formerly Hypred) was created in 1985 as a subsidiary of the Roullier Group, and has progressively expanded geographically to hold growing positions in Europe and the rest of the world (notably in South America). Kersia is specialized in the formulation, production and sale of food safety, bio-security and disinfection solutions, mainly for the food processing and farming industries. In addition, the company has also developed feed-additive and water-disinfection product ranges. Kersia is present in more than 80 countries, operates directly more than 10 industrial sites (and has in parallel several toll manufacturing partnerships) and employs more than 900 FTEs. The company enjoys solid competitive advantages in R&D, innovation and regulatory practice, which is key to meet and anticipate customers’ needs and comply with constantly evolving regulation and sanitary threats.
Deal team
Press releases
- IK Investment Partners enters exclusive negotiations with Ardian for the acquisition of Kersia
- Ardian-backed Kersia acquires Manchester-based Holchem, and becomes Europe's second largest food safety company
- Hypred to combine with Anti-Germ
- Ardian-backed Kersia acquires Choisy laboratories
Articles
-
BuyoutDedalus
Italy
Healthcare & life scienceHealthcare & life scienceDedalus is a global healthcare software company and one of the largest in the world, offering leading solutions covering the entire spectrum of the continuum of care, helping the healthcare organizations to deliver new models of care. Today the company supports over 7,500 healthcare organizations and 5,700 labs and diagnostic centers worldwide, processing its solutions for more than 540 million population worldwide and managing each year more than 4 billion diagnostic results. Today, the group employs more than 7,000 highly skilled qualified people and has the largest software R&D team in the industry in Europe (∼40% of workforce).
Deal team
Press releases
-
BuyoutEnvision Pharma
United-Kingdom
Healthcare & life scienceExited
Healthcare & life scienceEnvision Pharma is an international, innovative global technology and scientific communication company serving pharmaceutical, biotechnology, and medical device companies. Envision currently provides service and product solutions to more than 75 client companies, including 18 of the top 20 pharmaceutical companies. Envision currently has ten offices, three in the United Kingdom, five in the United States, two in Asia Pacific, and employs around 450 team members.